The Europe pain management drugs market hit US$17.13 billion in 2024 and is expected to surge at a 7.9% CAGR, reaching US$33.77 billion by 2033, as pharmaceutical innovation—including novel NSAIDs and GABA-receptor modulators—gains momentum https://www.datamintelligence.com/research-report/europe-pain-management-drugs-market